OrthoPediatrics Corp
KIDS16.650USD
+0.060+0.36%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
417.54MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über OrthoPediatrics Corp Unternehmen
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
OrthoPediatrics Corp Informationen
BörsenkürzelKIDS
Name des UnternehmensOrthoPediatrics Corp
IPO-datumOct 12, 2017
CEOBailey (David R)
Anzahl der mitarbeiter562
WertpapierartOrdinary Share
GeschäftsjahresendeOct 12
Addresse2850 Frontier Drive
StadtWARSAW
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl46582
Telefon15742686379
Websitehttps://www.orthopediatrics.com/
BörsenkürzelKIDS
IPO-datumOct 12, 2017
CEOBailey (David R)
Führungskräfte von OrthoPediatrics Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David R. Bailey
Mr. David R. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
317.56K
-1600.00%
Mr. Fred L. Hite
Mr. Fred L. Hite
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
213.06K
+5076.00%
Mr. Mark C. Throdahl
Mr. Mark C. Throdahl
Chairman of the Board
Chairman of the Board
190.38K
+8401.00%
Mr. Gregory A. Odle
Mr. Gregory A. Odle
President of Scoliosis
President of Scoliosis
148.79K
+33414.00%
Mr. Joseph W. Hauser
Mr. Joseph W. Hauser
President of Trauma, Deformity and OPSB
President of Trauma, Deformity and OPSB
137.66K
+46869.00%
Mr. David R. Pelizzon
Mr. David R. Pelizzon
Independent Director
Independent Director
32.95K
+8401.00%
Mr. Bryan W. Hughes
Mr. Bryan W. Hughes
Independent Director
Independent Director
21.23K
+8401.00%
Mr. Samuel D. Riccitelli
Mr. Samuel D. Riccitelli
Independent Director
Independent Director
20.42K
+8401.00%
Ms. Marie C. Infante, J.D.
Ms. Marie C. Infante, J.D.
Independent Director
Independent Director
19.77K
+8401.00%
Ms. Kelly Fischer
Ms. Kelly Fischer
Director
Director
4.34K
+4345.00%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David R. Bailey
Mr. David R. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
317.56K
-1600.00%
Mr. Fred L. Hite
Mr. Fred L. Hite
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
213.06K
+5076.00%
Mr. Mark C. Throdahl
Mr. Mark C. Throdahl
Chairman of the Board
Chairman of the Board
190.38K
+8401.00%
Mr. Gregory A. Odle
Mr. Gregory A. Odle
President of Scoliosis
President of Scoliosis
148.79K
+33414.00%
Mr. Joseph W. Hauser
Mr. Joseph W. Hauser
President of Trauma, Deformity and OPSB
President of Trauma, Deformity and OPSB
137.66K
+46869.00%
Mr. David R. Pelizzon
Mr. David R. Pelizzon
Independent Director
Independent Director
32.95K
+8401.00%
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Trauma and Deformity
44.14M
72.07%
Scoliosis
16.26M
26.55%
Sports Medicine and Other
846.00K
1.38%
Nach RegionUSD
Name
Umsatz
Anteil
U.S.
48.72M
79.54%
International
12.53M
20.46%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Trauma and Deformity
44.14M
72.07%
Scoliosis
16.26M
26.55%
Sports Medicine and Other
846.00K
1.38%
Aktionärsstatistik
Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Squadron Capital LLC
27.52%
Brown Advisory
7.56%
Millennium Management LLC
5.55%
Braidwell LP
4.42%
Morgan Stanley & Co. LLC
4.38%
Andere
50.58%
Aktionäre
Aktionäre
Anteil
Squadron Capital LLC
27.52%
Brown Advisory
7.56%
Millennium Management LLC
5.55%
Braidwell LP
4.42%
Morgan Stanley & Co. LLC
4.38%
Andere
50.58%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
27.53%
Corporation
27.52%
Investment Advisor
23.48%
Hedge Fund
13.50%
Individual Investor
5.19%
Research Firm
4.96%
Pension Fund
0.84%
Bank and Trust
0.20%
Insurance Company
0.02%
Institutionelle Beteiligung
Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
286
17.69M
70.55%
-1.38M
2025Q3
290
16.80M
66.98%
-2.63M
2025Q2
307
26.06M
103.94%
-977.48K
2025Q1
321
26.03M
105.09%
-1.19M
2024Q4
319
25.60M
105.70%
-1.27M
2024Q3
325
25.26M
104.34%
-2.01M
2024Q2
325
25.18M
104.01%
-1.27M
2024Q1
329
24.43M
104.11%
-1.85M
2023Q4
333
24.59M
105.32%
-1.43M
2023Q3
324
24.49M
104.97%
-1.38M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Squadron Capital LLC
6.90M
27.52%
--
--
Mar 28, 2025
Brown Advisory
1.89M
7.56%
+270.00K
+16.62%
Sep 30, 2025
Millennium Management LLC
1.39M
5.55%
+447.00K
+47.37%
Oct 29, 2025
Braidwell LP
1.11M
4.42%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
1.10M
4.38%
+490.05K
+80.48%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.09M
4.33%
-21.40K
-1.93%
Sep 30, 2025
Brown Capital Management, LLC
1.08M
4.31%
-475.48K
-30.54%
Sep 30, 2025
Wellington Management Company, LLP
1.02M
4.09%
-2.19K
-0.21%
Sep 30, 2025
The Vanguard Group, Inc.
958.03K
3.82%
+10.93K
+1.15%
Sep 30, 2025
Granahan Investment Management, LLC
759.95K
3.03%
-206.88K
-21.40%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Invesco NASDAQ Future Gen 200 ETF
0.42%
State Street SPDR S&P Health Care Equipment ETF
0.39%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.09%
iShares Micro-Cap ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.04%
Avantis US Small Cap Equity ETF
0.03%
WisdomTree US SmallCap Fund
0.02%
Humankind US Stock ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Mehr Anzeigen
Invesco NASDAQ Future Gen 200 ETF
Anteil0.42%
State Street SPDR S&P Health Care Equipment ETF
Anteil0.39%
SPDR SSGA US Small Cap Low Volatility Index ETF
Anteil0.09%
iShares Micro-Cap ETF
Anteil0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.04%
Avantis US Small Cap Equity ETF
Anteil0.03%
WisdomTree US SmallCap Fund
Anteil0.02%
Humankind US Stock ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
